Famotidine tablets

The Defense Logistics Agency, through its SPE2DP office, is soliciting quotes under Request for Quotation SPE2DP27T0273 for famotidine tablets (NSN 6505-01-310-4178) on behalf of DLA Troop Support Medical, with quotes due November 17, 2026. The Set Aside line reads "No Set-Aside Used," and the attachment summary confirms this is not a small business set-aside.

The requirement is four packages (PG) on line 0001, with delivery required within five days, FOB destination, and inspection at destination under FAR 52.246-2. Quotes must be submitted through the DLA Internet Bid Board System (DIBBS). The solicitation type is Fast Auto Evaluation. The PSC is 6505, Drugs and Biologicals.

Per the attached RFQ summary, each package contains 100 tablets of 20 mg, and delivery is to Worcester, Massachusetts (W51JK3, 0182 MD CO Medical Company, 701 Lincoln Street). The same summary lists these requirements: packaging per RP001, a 30-month non-extendable shelf life per RS019, Medical Marking Standard No. 1 compliance, and Buy American Act and Berry Amendment domestic sourcing. The product is FDA-regulated, and the summary names Mylan Institutional (formerly UDL, NDC 51079-0966-20) and McKesson Corporation (NDC 63739-0645-10) as approved sources. Recent awards in the attachment's procurement history ranged from $7.60 to $7.96 per unit.